A β1-adrenergic receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ICI 89406

Item No. 42370

Technical Information
Formal Name
N-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-N'-phenyl-urea
CAS Number
53671-71-9
Molecular Formula
C19H22N4O3
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly Soluble: 1-10 mg/mL
SMILES
N#CC(C=CC=C1)=C1OCC(O)CNCCNC(NC2=CC=CC=C2)=O
InChi Code
InChI=1S/C19H22N4O3/c20-12-15-6-4-5-9-18(15)26-14-17(24)13-21-10-11-22-19(25)23-16-7-2-1-3-8-16/h1-9,17,21,24H,10-11,13-14H2,(H2,22,23,25)
InChi Key
HTLWRKRZKFAAAH-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ICI 89406 is an antagonist of ß1-adrenergic receptors (IC50 = 4.2 nM).1 It is selective for ß1-adrenergic receptors over ß2-adrenergic receptors (IC50 = 678 nM). ICI 89406 also acts as a partial agonist at ß1- and ß2-adrenergic receptors, inducing cAMP accumulation in CHO-K1 cells expressing the human receptors (EC50s = 0.81 and 60.26 nM, respectively).2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nanoff, C., Freissmuth, M., and Schütz, W. The role of a low β1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch. Pharmacol. 336(5), 519-525 (1987).

    2. Mistry, S.N., Baker, J.G., Fischer, P.M., et alSynthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. J. Med. Chem. 56(10), 3852-3865 (2013).